Research Labs

The Romesser lab studies colorectal and anal cancer with a focus on using radiotherapy to treat disease.

Pharmacologist Neal Rosen focuses on understanding biochemical mechanisms underlying phenotypes caused by tyrosine kinase activation in epithelial tumors and developing new therapeutic strategies.

Physician-scientist Veronica Rotemberg studies imaging standards and artificial intelligence (AI) for dermatology applications.

Immunology Program Chair Alexander Rudensky focuses on immunological tolerance and the differentiation and function of T cells.

Physician-scientist Charles Rudin focuses on the development and testing of novel therapeutic approaches to lung cancer in preclinical models.

Cell biologist Timothy Ryan studies the molecular basis of synaptic transmission in the mammalian brain.

Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.

Molecular Pharmacology Program Member David Scheinberg focuses on the discovery and development of novel, specific immunotherapeutic agents and targeted nanodevices for cancer therapy.

Cancer Immunologist Andrea Schietinger investigates immune responses to cancer, molecular mechanisms underlying tumor-induced T cell dysfunction, and new approaches for cancer immunotherapy.

Physician-scientist Adam Schmitt studies how long noncoding RNAs regulate cellular stress responses and tumor development.